Enanta Pharmaceuticals (ENTA) Stock Chart & Stock Price History → AI Cracks Open Largest Untapped Energy Reserve on Earth (From Banyan Hill Publishing) (Ad) Free ENTA Stock Alerts $13.51 -0.70 (-4.93%) (As of 03/18/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Enanta Pharmaceuticals Stock Price Performance5 Day Performance-6.44%1 Month Performance+4.00%3 Month Performance+51.12%6 Month Performance+6.97%Year-To-Date Performance+43.57%1 Year Performance-67.90% Receive ENTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Prosper Trading AcademyDid you make $29,000 two days with AI options trades?What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:Click Here To Get Your Free Copy ENTA Stock Chart for Monday, March, 18, 2024 ENTA Chart by TradingView Enanta Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/18/2024$14.21$13.51-4.93%$14.15$13.49156,133 shs$285.87 million03/15/2024$13.86$14.21+2.53%$14.37$13.71196,538 shs$300.63 million03/14/2024$14.44$13.86-4.02%$14.56$13.74100,846 shs$293.28 million03/13/2024$14.54$14.44-0.69%$14.79$14.37168,984 shs$305.55 million03/12/2024$15.08$14.54-3.58%$15.08$14.51113,125 shs$307.67 million03/11/2024$15.40$15.08-2.08%$15.67$15.02208,028 shs$319.03 million Get the Latest News and Ratings for ENTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/08/2024$15.72$15.40-2.04%$16.23$15.09285,169 shs$325.86 million03/07/2024$15.66$15.72+0.38%$16.05$15.50309,790 shs$332.64 million03/06/2024$15.06$15.66+3.98%$15.70$14.99142,006 shs$331.30 million03/05/2024$15.65$15.06-3.77%$16.03$14.66236,812 shs$318.67 million03/04/2024$15.35$15.65+1.95%$15.80$15.06239,211 shs$331.15 million03/01/2024$14.37$15.35+6.82%$15.68$14.19322,620 shs$324.81 million02/29/2024$14.30$14.37+0.49%$14.71$14.10181,510 shs$304.07 million02/28/2024$14.05$14.30+1.78%$14.59$13.92220,324 shs$302.59 million02/27/2024$14.04$14.05+0.07%$14.42$13.88235,705 shs$297.30 million02/26/2024$13.46$14.04+4.31%$14.19$13.46200,677 shs$297.09 million02/23/2024$12.51$13.46+7.59%$13.50$12.53199,643 shs$284.81 million02/22/2024$12.98$12.51-3.62%$13.01$12.27266,139 shs$264.71 million02/21/2024$12.79$12.98+1.49%$13.03$12.78101,962 shs$274.61 million02/20/2024$12.99$12.79-1.54%$13.16$12.70196,920 shs$270.64 million02/19/2024$12.99$12.99$13.36$12.94211,800 shs$274.87 million02/16/2024$13.26$12.99-2.04%$13.36$12.94207,778 shs$274.87 million02/15/2024$13.21$13.26+0.38%$13.84$13.16325,786 shs$280.58 million02/14/2024$12.31$13.21+7.31%$13.40$12.30247,226 shs$279.52 million02/13/2024$12.33$12.31-0.16%$12.43$11.92343,324 shs$260.48 million02/12/2024$12.34$12.33-0.08%$12.58$12.24560,411 shs$260.90 million02/09/2024$12.36$12.34-0.16%$12.50$12.18394,415 shs$261.11 million02/08/2024$12.26$12.36+0.82%$12.50$11.01436,633 shs$261.54 million02/07/2024$12.54$12.26-2.23%$12.63$12.15172,772 shs$259.42 million02/06/2024$12.37$12.54+1.37%$12.99$12.14138,746 shs$265.30 million02/05/2024$12.28$12.37+0.73%$12.40$11.82183,090 shs$261.75 million02/02/2024$12.78$12.28-3.91%$12.67$12.22191,682 shs$259.85 million02/01/2024$12.15$12.78+5.19%$12.96$12.16132,570 shs$270.43 million01/31/2024$12.20$12.15-0.41%$12.46$12.14144,000 shs$257.09 million01/30/2024$12.52$12.20-2.56%$12.49$12.17203,941 shs$256.93 million01/29/2024$12.23$12.52+2.37%$12.58$11.96189,034 shs$263.67 million01/26/2024$12.29$12.23-0.49%$12.68$12.12127,887 shs$257.56 million01/25/2024$12.10$12.29+1.57%$12.67$12.00248,664 shs$258.83 million01/24/2024$12.19$12.10-0.74%$12.40$12.06190,046 shs$254.83 million01/23/2024$11.79$12.19+3.39%$12.38$11.77184,228 shs$256.72 millionThey said crypto was dead. It went up 100X. (Ad)Bitcoin’s haters are out again. Despite the price doubling in the last six months alone… That hasn’t stopped the experts from piling on. Warren Buffett’s right-hand man Charlie Munger called crypto investors “idiots” in one of his last interviews. JPMorgan CEO Jamie Dimon, recently called Bitcoin a “pet rock” and “a hyped-up fraud.” But when it comes to cryptos, these are exactly the people you shouldn’t listen to. They’ve predicted crypto’s demise for years.There are five coins you must take a look at right away.01/22/2024$11.71$11.79+0.68%$12.13$11.60271,441 shs$248.29 million01/19/2024$11.62$11.71+0.77%$11.77$11.32166,780 shs$246.61 million01/18/2024$11.88$11.62-2.19%$12.23$11.49313,601 shs$244.72 million01/17/2024$11.26$11.88+5.51%$12.07$10.78363,000 shs$237.12 million01/16/2024$11.21$11.26+0.45%$11.35$10.74452,977 shs$237.14 million01/15/2024$11.21$11.21$11.78$11.10207,800 shs$236.08 million01/12/2024$11.31$11.21-0.88%$11.78$11.10207,836 shs$236.07 million01/11/2024$11.94$11.31-5.28%$11.91$11.26445,156 shs$238.19 million01/10/2024$11.87$11.94+0.59%$12.20$11.29333,215 shs$251.46 million01/09/2024$12.41$11.87-4.35%$12.46$11.82346,558 shs$249.98 million01/08/2024$12.11$12.41+2.48%$12.72$11.69473,222 shs$261.36 million01/05/2024$12.04$12.11+0.58%$12.20$11.12363,429 shs$255.04 million01/04/2024$10.58$12.04+13.80%$12.22$10.60752,250 shs$253.56 million01/03/2024$10.08$10.58+4.96%$10.64$9.87388,748 shs$222.82 million01/02/2024$9.41$10.08+7.12%$10.37$9.24346,476 shs$212.29 million01/01/2024$9.41$9.41$9.76$9.40175,700 shs$198.17 million12/29/2023$9.76$9.41-3.59%$9.76$9.40175,702 shs$198.18 million12/28/2023$9.65$9.76+1.14%$9.89$9.49188,704 shs$205.55 million12/27/2023$9.45$9.65+2.12%$9.84$9.37162,651 shs$203.23 million12/26/2023$9.15$9.45+3.28%$9.51$9.08116,111 shs$199.02 million12/25/2023$9.15$9.15$9.48$8.85137,200 shs$192.69 million12/22/2023$8.89$9.15+2.92%$9.48$8.86137,289 shs$192.69 million12/21/2023$8.52$8.89+4.34%$8.90$8.51112,098 shs$187.22 million12/20/2023$9.21$8.52-7.49%$9.21$8.52163,575 shs$179.43 million12/19/2023$8.94$9.21+3.02%$9.35$9.01196,836 shs$193.96 million12/18/2023$9.34$8.94-4.28%$9.40$8.92120,127 shs$188.28 million Related Companies: XERS Stock Chart NBTX Stock Chart GOSS Stock Chart ATAI Stock Chart ANL Stock Chart STOK Stock Chart ACIU Stock Chart XOMA Stock Chart ERAS Stock Chart NATR Stock Chart Receive ENTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enanta Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENTA) was last updated on 3/18/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial MetalsLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & CompanyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.